Company Filing History:
2 out of 2 
2 out of 2 
2 out of 282 
Years Active: 2024-2025
Title: Harri Lempiäinen: Innovator in Cancer Detection
Introduction
Harri Lempiäinen is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of cancer detection through his innovative research and patents. His work focuses on the development of methods for identifying and managing certain cancers, particularly ovarian cancer.
Latest Patents
Harri Lempiäinen holds 2 patents related to epigenetic markers and their application in cancer detection. His latest patent involves methods for determining the presence or absence of certain cancers in individuals. This invention utilizes the detection of methylated or unmethylated CpGs associated with differentially methylated regions (DMRs) in cell-free DNA. The methods developed have diagnostic, prognostic, and predictive utility for managing cancers, especially in women.
Career Highlights
Throughout his career, Harri has worked with prominent companies in the genomics and biotechnology sectors. He has been associated with Eurofins Genomics Europe Sequencing GmbH and Genedata AG, where he contributed to advancements in genomic sequencing and data analysis.
Collaborations
Harri has collaborated with esteemed colleagues in his field, including Martin Widschwendter and Allison Jones. Their joint efforts have furthered the understanding and application of epigenetic markers in cancer research.
Conclusion
Harri Lempiäinen's innovative work in cancer detection through epigenetic markers has the potential to significantly impact the medical field. His contributions are paving the way for improved diagnostic and therapeutic strategies in oncology.